Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-07

Clinical Trial Update: 18F-AV-1451 Autopsy Study [Phase 3]

View source ↗

Summary

Phase 3 autopsy study update for 18F-AV-1451 in Alzheimer's disease; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 18F-AV-1451 (flortaucipir)

Snippet

Sponsor: Avid Radiopharmaceuticals | Conditions: Alzheimer's Disease | Phase 3 | Status: COMPLETED | Results posted: 2020-09-07